Clinical Trial Update: Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating everolimus in patients with metastatic renal cell carcinoma after progression on bevacizumab has completed, reporting results from th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Metastatic Renal Cell Carcinoma | Phase 4 | Status: COMPLETED